IMPACT BIOMEDICAL INC.

IBO

IMPACT BIOMEDICAL INC.

IBO

Insider Sentiment (TTM):

Last Purchase:2025-03-20Last Sale:2026-03-27Shares Purchased (TTM):0Shares Sold (TTM):93,400

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:3,722,225Shares Outstanding:107,785,675Institutional Ownership Pct.:3.45%

Earnings Market Reaction:

Filing Date:2026-08-07Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	-	0	0	0	1	1	2	3	0	0	0	0
Other Receivables	-	-	-	-	-	-	-	-	-	-	0	-
Other Receivables Net Current	-	-	-	-	-	-	-	-	-	-	0	-
Accounts Receivable Net Current	-	-	0	0	-	0	-	-	0	0	-	-
Inventory Net	0	0	0	0	0	0	-	-	-	-	-	-
Notes And Loans Receivable Net Current	0	0	0	0	0	0	0	0	0	0	0	0
Prepaid Expense And Other Assets Current	0	0	0	0	0	0	0	0	0	0	-	0
Assets Current	0	0	0	1	1	2	2	3	0	0	0	1
Property Plant And Equipment Net	-	-	-	0	0	0	0	0	0	0	0	0
Notes And Loans Receivable Net Noncurrent	-	-	-	-	-	-	0	0	0	-	-	-
Goodwill	-	-	-	-	-	-	-	25	25	25	25	46
Other Intangible Assets Net	16	17	17	17	18	18	18	18	18	19	19	19
Assets	17	17	17	18	19	20	20	47	44	44	45	45
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	0	0	0	1	1	1	0	1	1	1	1	0
Accrued Liabilities Current	0	0	0	0	0	0	0	0	0	0	0	0
Notes Payable Current	-	-	-	23	22	9	9	0	13	13	12	12
Other Liabilities Current	1	1	1	-	-	-	0	-	-	-	-	-
Liabilities Current	2	2	1	24	23	10	10	1	14	14	13	12
Long Term Notes Payable	-	-	-	-	-	-	-	8	-	-	-	-
Deferred Income Tax Liabilities Net	1	1	1	3	3	3	3	3	3	3	3	3
Liabilities	3	2	2	27	26	13	13	12	-	-	16	16
Stockholders Equity Inclu…
Preferred Stock Value	-	-	-	0	0	0	0	0	0	0	0	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	63	63	62	43	43	43	42	42	38	38	38	38
Retained Earnings Accumulated Deficit	-52	-52	-50	-55	-53	-39	-38	-11	-15	-14	-13	-12
Stockholders Equity	11	11	16	-9	-10	4	7	31	23	27	25	27
Minority Interest	3	3	3	3	3	3	3	3	3	3	3	3
Liabilities And Stockholders Equity	17	17	17	18	19	20	20	47	44	44	45	45
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	-
Preferred Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	-
Preferred Stock Shares Issued	0	0	0	60	60	60	60	60	60	60	60	-
Preferred Stock Shares Outstanding	0	0	0	60	60	60	60	60	60	60	60	-
Preferred Stock Liquidation Preference	-	-	0	0	0	0	0	0	0	-	0	-
Preferred Stock Liquidation Preference Value	-	-	0	-	60	0	60,496	0	0	-	0	-
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	4,000	4,000	4,000	4,000	4,000	4,000	4,000	4,000	4,000	4,000	4,000	4,000
Common Stock Shares Issued	108	108	105	12	12	12	12	12	10	10	10	70
Shares Outstanding	108	108	105	12	12	12	12	12	10	10	10	70

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-9.28%	-24.48%	-31.20%	-	-	-	-	-	-	-	-	-
2025	-9.60%	25.34%	17.85%	6.70%	12.17%	-5.64%	-19.06%	-9.62%	-14.34%	7.45%	19.45%	-5.45%
2024	-	-	-	-	-	-	-24.51%	-38.98%	-38.27%	-73.49%	-64.41%	-70.39%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.16	0.22	0.35	0.04	0.06	0.22	0.25	2.79	0.02	0.02	0.03	0.04
Quick Ratio	0.10	0.13	0.18	0.01	0.04	0.15	0.22	2.47	0.02	0.02	0.03	0.03
Working Capital	-1.73M	-1.31M	-751.00K	-22.88M	-21.69M	-7.79M	-7.34M	2.04M	-14.19M	-13.52M	-12.80M	-11.77M
Leverage & Debt
Debt to Equity	0.25	0.21	0.12	-3.06	-2.56	3.45	1.80	0.39	0.62	0.51	0.58	0.58
Interest Coverage TTM	-19.21	-10.57	-5.37	-27.63	-26.71	-26.21	-27.00	-4.37	-5.39	-7.12	-	-
Debt Ratio	0.16	0.14	0.11	1.49	1.39	0.66	0.64	0.26	0.33	0.31	0.37	0.34
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-
Days Sales Outstanding TTM	-	-	57.03	219.00	-	-	-	-	-	-	-	-
Receivables Turnover TTM	-	-	6.40	1.67	-	0.00	-	-	0.00	0.00	-	-
Per Share Metrics
Diluted EPS TTM	0.01	-0.12	2.43	-3.63	-3.16	-2.08	0.30	0.00	-0.51	-0.53	-	-
Free Cash Flow Per Share TTM	-0.01	-0.02	-0.06	-0.19	-0.22	-0.25	-0.27	-0.20	-0.20	-0.33	-	-
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-
Margin Metrics
Operating Profit Margin TTM	-14,600.00%	-14,258.97%	-13,381.25%	-117,360.00%	-421,700.00%	-	-	-	-	-	-	-
Net Profit Margin TTM	2,168.57%	-33,043.59%	-37,093.75%	-176,992.00%	-550,457.14%	-	-	-	-	-	-	-
Growth Metrics
Net Revenue Growth (1Y)	400.00%	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth (1Y)	-101.97%	-48.61%	-52.08%	-14,014.47%	657.76%	373.29%	-	-	-	-	-	-
EPS Growth (1Y)	-100.22%	-94.25%	-83.66%	-13,236.31%	521.65%	292.36%	-	-	-	-	-	-
Valuation Metrics
P/E TTM	65.35	-5.02	-1.34	-0.18	-0.20	-0.42	-0.63	72.35	-	-	-	-
P/B TTM	4.61	5.64	1.02	-0.92	-0.76	2.73	2.16	0.73	-	-	-	-
P/S TTM	1,417.08	1,658.24	497.91	324.13	1,126.28	-	-	-	-	-	-	-
Market Cap	49.60M	64.67M	15.93M	8.10M	7.88M	10.49M	15.60M	23.01M	-	-	-	-
Enterprise Value	49.60M	64.65M	15.93M	30.97M	29.61M	18.32M	22.48M	28.35M	-	-	-	-
Calculated Values
Free Cash Flow TTM	-726.00K	-1.67M	-1.89M	-2.29M	-2.68M	-3.05M	-2.85M	-2.30M	-1.97M	-3.33M	-	-
Net Debt	0.00	-20.00K	-3.00K	22.87M	21.73M	7.82M	6.88M	5.34M	13.45M	12.79M	12.07M	11.58M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-03-27Sale

Owner: Macko, Todd D

Title: Chief Financial Officer

Shares: 43,400

Price/Share: $0.56

Value: $24,304.00

Shares Owned: 155,122

Relationship: Officer

Ownership: Direct

2026-03-23Sale

Owner: Grady, Jason

Title: -

Shares: 50,000

Price/Share: $0.65

Value: $32,500.00

Shares Owned: 250,182

Relationship: Director

Ownership: Direct

2025-05-27Sale

Owner: Dss,, Inc.

Title: -

Shares: 45,400

Price/Share: $0.54

Value: $24,516.00

Shares Owned: -

Relationship: TenPercentOwner

Ownership: Direct

2025-05-27Sale

Owner: Dss,, Inc.

Title: -

Shares: 45,400

Price/Share: $0.54

Value: $24,516.00

Shares Owned: 545,024

Relationship: TenPercentOwner

Ownership: Direct

2025-04-04Sale

Owner: Alset, Inc., Alset Intern…

Title: -

Shares: 180,000

Price/Share: $0.96

Value: $172,800.00

Shares Owned: -

Relationship: Director,TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-03-27	Macko, Todd D	Officer	Chief Financial Officer	Direct	Sale	43,400	0.56	$24,304.00	155,122	4
2026-03-23	Grady, Jason	Director	-	Direct	Sale	50,000	0.65	$32,500.00	250,182	4
2025-05-27	Dss,, Inc.	TenPercentOwner	-	Direct	Sale	45,400	0.54	$24,516.00	0	4
2025-05-27	Dss,, Inc.	TenPercentOwner	-	Direct	Sale	45,400	0.54	$24,516.00	545,024	4
2025-04-04	Alset, Inc., Alset Intern…	Director,TenPercentOwner	-	Indirect	Sale	180,000	0.96	$172,800.00	0	4
2025-04-04	Dss,, Inc.	TenPercentOwner	-	Direct	Sale	890,800	0.95	$846,260.00	161,100	4
2025-04-03	Chan, Heng Fai Ambrose	Director	-	Indirect	Sale	351,555	0.50	$175,777.50	0	4
2025-04-01	Alset, International Ltd,…	Director,TenPercentOwner	-	Indirect	Sale	2,226,918	1.17	$2,605,494.06	734,058	4
2025-03-27	Dss,, Inc.	TenPercentOwner	-	Direct	Sale	47,681	2.50	$119,202.50	1,051,800	4
2025-03-20	Dss,, Inc.	TenPercentOwner	-	Indirect	Sale	53,280	4.68	$249,350.40	0	4
2025-03-20	Dss,, Inc.	TenPercentOwner	-	Indirect	Purchase	200	1.55	$310.00	53,280	4
2024-12-05	Heuszel, Frank D	Director,Officer	Chief Executive Officer	Direct	Purchase	500	2.26	$1,130.00	97,344	4
2024-11-27	Heuszel, Frank D	Director,Officer	Chief Executive Officer	Direct	Purchase	500	2.61	$1,305.00	96,844	4
2024-11-26	Heuszel, Frank D	Director,Officer	Chief Executive Officer	Direct	Purchase	1,050	2.61	$2,740.50	96,344	4
2024-11-18	Dss,, Inc.	TenPercentOwner	-	Indirect	Sale	5,000	3.02	$15,100.00	53,100	4
2024-09-18	Dss,, Inc.	TenPercentOwner	-	Indirect	Purchase	1,000	2.33	$2,330.00	58,800	4
2024-09-17	Dss,, Inc.	TenPercentOwner	-	Indirect	Purchase	7,800	2.40	$18,720.00	57,800	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

3.45%

Inst. Shares: 3,722,225

Shares Outstanding: 107,785,675

2025-12-31

4.52%

Inst. Shares: 1,426,279

Shares Outstanding: 31,550,457

2025-09-30

4.42%

Inst. Shares: 538,187

Shares Outstanding: 12,185,412

2025-06-30

3.79%

Inst. Shares: 461,354

Shares Outstanding: 12,185,412

2025-03-31

2.33%

Inst. Shares: 281,371

Shares Outstanding: 12,062,743

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	3,722,225	107,785,675	3.45%
2025-12-31	1,426,279	31,550,457	4.52%
2025-09-30	538,187	12,185,412	4.42%
2025-06-30	461,354	12,185,412	3.79%
2025-03-31	281,371	12,062,743	2.33%
2024-12-31	40,102	10,757,147	0.37%
2024-09-30	16,061	11,503,955	0.14%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

IMPACT BIOMEDICAL INC. (IBO) — SEC Financial Statements & Analysis

IMPACT BIOMEDICAL INC. (IBO) is a pharmaceutical preparations company, incorporated in NV. IMPACT BIOMEDICAL INC. trades on NYSE as: IBO. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), IMPACT BIOMEDICAL INC. reported a 400.00% year-over-year revenue growth, a Debt-to-Equity ratio of 0.25x, a Price-to-Sales (P/S) ratio of 1417.08x (TTM), a Price-to-Book (P/B) ratio of 4.61x (TTM), at a market cap of $49.60M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 400.00%
Debt To Equity: 0.25x
P/S TTM: 1417.08x
P/B TTM: 4.61x
Market Cap: $49.60M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is IMPACT BIOMEDICAL INC. in?

IMPACT BIOMEDICAL INC. (IBO) operates in the Pharmaceutical Preparations industry.

What is IBO's market cap?

IMPACT BIOMEDICAL INC. (IBO) has a market capitalization of $49.60M as of 2026-06-30.

What is IBO's P/E ratio?

IMPACT BIOMEDICAL INC. (IBO)'s trailing twelve month P/E ratio is 65.35x as of 2026-06-30.

What exchange does IBO trade on?

IMPACT BIOMEDICAL INC. (IBO) trades on the NYSE.

Where is IMPACT BIOMEDICAL INC. incorporated?

IMPACT BIOMEDICAL INC. is incorporated in NV.